Most Read Articles
20 Jun 2020
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.
Stephen Padilla, 15 Jun 2020
Consumption of whole almonds as snacks not only reduces low-density lipoprotein cholesterol (LDL-C) but also significantly improves endothelial function in adults with above-average risk of cardiovascular disease (CVD), according to the results of a trial.
Pearl Toh, 3 days ago
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.

Daily aspirin use may prevent fibrosis progression in nonalcoholic fatty liver disease

08 Jun 2019

Use of aspirin on a daily basis appears to be associated with less severe histologic features of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), as well as reduce the risk of progression to advanced fibrosis with time, a study has found.

Researchers examined 361 adults with biopsy-confirmed NAFLD every 3–12 months for incident advanced fibrosis defined using serial measurements of validated indices (the Fibrosis-4, NAFLD fibrosis score and aspartate aminotransferase to platelet ratio indices). Liver biopsies were collected at baseline for histologic analyses.

At baseline, 151 patients reported daily aspirin use. Compared with nonregular users, daily users had a significantly lower likelihood of NASH (adjusted odds ratio [aOR], 0.68, 95 percent CI, 0.37–0.89) and fibrosis (aOR, 0.54, 0.31–0.82).

In the group of patients with baseline F0-F2 fibrosis (n=317), 86 developed advanced fibrosis over 3,692 person-years. Daily aspirin use was associated with a significantly lower risk of developing incident advanced fibrosis compared with nonregular users (adjusted hazard ratio [aHR], 0.63, 0.43–0.85).

The relationship between fibrosis progression and aspirin use was dependent of duration of use (p-trend=0.026), with the greatest benefit found in daily aspirin users for 4 years (aHR, 0.50, 0.35–0.73).

In contrast, use of nonaspirin nonsteroidal anti-inflammatory drugs was not associated with the risk of advanced fibrosis (aHR, 0.93, 0.81–1.05).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
20 Jun 2020
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.
Stephen Padilla, 15 Jun 2020
Consumption of whole almonds as snacks not only reduces low-density lipoprotein cholesterol (LDL-C) but also significantly improves endothelial function in adults with above-average risk of cardiovascular disease (CVD), according to the results of a trial.
Pearl Toh, 3 days ago
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.